Высокое качество Ингибитор рапамицина, Ингибитор Эверолимуса, Ингибитор PI-103 Поставщики в Китае

Описание продукта

.cp_wz table {border-top: твердое тело 1px #ccc; border-left: твердое тело 1px #ccc; } .cp_wz таблица td {border-right: 1px solid #ccc; нижняя граница: сплошной 1px #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} \ n Молекулярный вес: 406,44 OSI-027 - селективный и мощный двойной ингибитор mTORC1 и mTORC2 с IC50 22 нМ и 65 нМ, и более чем 100-кратная селективность наблюдается для mTOR, чем для PI3Kα, PI3Kβ, PI3Kγ или ДНК-PK. Фаза 1. \ n OSI-027 демонстрирует активность селективного и конкурентного ингибирования АТФ против mTORC1 и mTORC2 с IC50 22 нМ и 65 нМ, соответственно. Кроме того, OSI-027 ингибирует передачу сигналов mTOR фосфо-4E-BP1 с IC50 1 мкМ в клеточных анализах. OSI-027 проявляет антипролиферативную активность против нескольких линий клеток острого лейкоза миелоидного / мегакариоцитарного происхождения в зависимости от дозы, включая клетки U937, KG-1, KBM-3B, ML-1, HL-60 и MEG-01. . Недавнее исследование показывает, что ингибирование mTORC1 / 2 с помощью OSI-027 эффективно подавляет фосфорилирование Akt (S473) и пролиферацию клеток рака молочной железы. В колоректальном ксенотрансплантате GEO OSI-027 (65 мг / кг) ингибирует эффекторы как mTORC1, так и mTORC2, включая фосфорилирование 4E-BP1, Akt и S6. Более того, совместное ингибирование mTORC1 и mTORC2 с помощью OSI-027 значительно подавляет рост опухоли в большей степени, чем ингибирование mTORC1 рапамицином. \ п
Biochemical assays mTORC1 and mTORC2 inhibition is assayed using native enzyme complex immunoprecipitated from HeLa lysates at 1 mM ATP. To prepare whole cell lysates from HeLa cells, 25 g cell pellet is lysed in 60 mL of ice-cold buffer A [40 mM HEPES (pH 7.5), 120 mM NaCl, 1 mM EDTA, 10 mM sodium pyrophosphate, 10 mM glycerophosphate, 50 mM NaF, 0.5 mM orthovanadate, and EDTA-free protease inhibitors containing 0.3% CHAPS] for 30 minutes on a magnetic stirrer in a cold room. After clearing of the lysates by centrifugation at 13,000 g for 10 minutes, Protein G-coated 384-well plates are incubated with 0.25 μg of mTOR antibody in 15 μL of buffer A for 1 hour at 4 °C. To each well, 40 μg of HeLa cell lysate in 15 μL of buffer A is added and incubated overnight at 4 °C to immunoprecipitate mTOR complexes. Plates are washed 3 times with buffer A and twice with immunoprecipitation wash buffer [Buffer B: 50 mM HEPES (pH 7.5) and 150 mM NaCl]. OSI-027 is added at 10 μM concentration to each well and DMSO is added to the control wells. The reaction is started by adding 150 ng of His-tagged 4E-BP1 as a substrate in the presence or absence of 100 μM ATP to each well in 25 μL of freshly prepared kinase buffer [Buffer C: 20 mM HEPES (pH 7.5), 10 mM MgCl2, 4 mM MnCl2, 10 mM β-mercaptoethanol, and 200 μM vanadate] and incubated at room temperature (RT) for 30 minutes. The reaction is stopped by transferring 25 μL of reaction mixture from each well to corresponding wells of fresh Ni-chelate-coated plates and incubated overnight at 4 °C followed by 2 hours at 37 °C. To detect phosphorylation of 4E-BP1, the plates are washed once with TBST (Tris-buffered saline containing 0.1% Tween-20) containing 5% skim milk powder. To each well, 25 μL of 1:1,000 diluted phospho-4E-BP1 antibodies in TBST containing 5% skim milk are added and incubated for 1 hour at RT. The plates are washed once with TBST and then 25 μL of anti-rabbit HRP (diluted 1:10,000) in TBST containing 5% skim milk is added. The plates are incubated for 1 hour at RT and washed 5 times with TBST. For detection of phospho-4E-BP1, 25 μL of chemiluminescent reagents A+B is added and chemiluminescence is measured using an Analyst plate reader.
Cell lines U937, KG-1, KBM-3B, ML-1, HL-60, and MEG-01
Concentrations 0-10 μM
Incubation Time 72 hours
Method

Inhibition of proliferation is measured using the Cell Titer Glo Assay , as noted in figure legends. To generate dose–response curves, cell lines are seeded at a density of 5,000 cells per well in a 96-well plate. After 24 hours of plating, cells are dosed with varying concentrations of either OSI-027 or rapamycin. The signal for Cell Titer Glo Assay is determined 72 hours after dosing and normalized to that of vehicle-treated controls. Inhibition of proliferation, relative to vehicle-treated controls, is expressed as a fraction of 1 and graphed using PRISM software.

Animal Models GEO colorectal cells are injected s.c. into the right flank of nu/nu CD-1 mice.
Formulation Dissolved in DMSO and then diluted in water.
Dosages ≤65 mg/kg
Administration Administered via gavage.
Solubility 1% DMSO/30% polyethylene glycol/1% Tween 80, 30 mg/mL
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Конверсия различных модельных животных на основе BSA (значение на основе данных из проекта рекомендаций FDA)
Species Baboon Dog Monkey Rabbit Guinea pig Rat Hamster Mouse
Weight (kg) 12 10 3 1.8 0.4 0.15 0.08 0.02
Body Surface Area (m2) 0.6 0.5 0.24 0.15 0.05 0.025 0.02 0.007
Km factor 20 20 12 12 8 6 5 3
Animal A (mg/kg) = Animal B (mg/kg) multiplied by Animal B Km
Animal A Km
Например, чтобы изменить дозу ресвератрола, используемую для мыши (22,4 мг / кг), на дозу, основанную на BSA для крысы, умножьте 22,4 мг / кг на коэффициент Km для мыши, а затем разделите на коэффициент Km для крыса. Этот расчет дает эквивалентную дозу ресвератрола для крыс 11,2 мг / кг.
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × mouse Km(3) = 11.2 mg/kg
rat Km(6)
Химическая информация
Molecular Weight (MW) 406.44
Formula

C21H22N6O3

CAS No. 936890-98-1
Storage 3 years -20℃Powder
6 months-80℃in solvent (DMSO, water, etc.)
Synonyms ASP4786
Solubility (25°C) * In vitro DMSO 18 mg/mL (44.28 mM)
Water <1 mg/mL (
Ethanol <1 mg/mL (
In vivo 1% DMSO/30% polyethylene glycol/1% Tween 80 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name (1r,4r)-4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[1,5-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid
Калькулятор молярности Калькулятор разведения Калькулятор молекулярной массы

Группа Продуктов : PI3K / Akt / mTOR > mTOR ингибитор